Articles: chronic.
-
COPD Epidemiology & Physiology PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: There is limited knowledge related to the prevalence and determinants of chronic bronchitis (CB) among Canadian First Nations people. The aim of the current study was to determine the prevalence of CB and associated risk factors among First Nations People. ⋯ The following authors have nothing to disclose: Punam Pahwa, Chandima Karunanayake, Donna Rennie, Kathleen McMullin, Josh Lawson, Jeremy Seeseequasis, Arnold Naytowhow, Akwasi Owusu-Kyem, Louise Hagel, Sylvia Abonyi, Jo-Ann Episkenew, James DosmanNo Product/Research Disclosure Information.
-
Physiology/PFTs/Rehabilitation PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Spirometry is recommended for the diagnosis of asthma and Chronic Obstructive Pulmonary Disease (COPD) in international guidelines and it may be useful for distinguishing asthma from COPD. Typically, the only data required for clinical decision making are the Forced Expiratory Volume in one second (FEV1) and the Forced Vital Capacity (FVC). Limitations of SIA promoted for adoption in primary care have been described [Can Fam Physician October 2011 57:1148-1152, 1153-1156.] This study examines how different SIA (one and two) may influence decision making among primary care physicians. ⋯ The following authors have nothing to disclose: Xiao Ou He, Anthony D'UrzoNo Product/Research Disclosure Information.
-
Critical Care Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Mirtazapine is an anti-depressant that is known to have minimal gastrointestinal side effects. There are only four case reports describing mirtazapine associated pancreatitis and one associated with hypertriglyceridemia. This case is of a woman who was admitted to the ICU with hypertriglyceridemia associated pancreatitis and subsequent diabetic ketoacidosis secondary to her use of Remeron. ⋯ The following authors have nothing to disclose: Jeffrey Stone, Nitin PuriNo Product/Research Disclosure Information.
-
DVT/PE PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To outline the resource use and costs a U.S. health plan can anticipate during the evaluation and first year of treatment of a CTEPH patient ⋯ Vijay Joish: Employee: employee of bayer sponsor of study Christine Divers: Employee: employee of bayer sponsor of study Chakkarin CBurudpakdee: Consultant fee, speaker bureau, advisory committee, etc.: consultant of bayer sponsor of study Anshul Shah: Consultant fee, speaker bureau, advisory committee, etc.: consultant of bayer sponsor of study Stephen Mathai: Consultant fee, speaker bureau, advisory committee, etc.: consultant to bayer sponsor of studyNo Product/Research Disclosure Information.
-
Respiratory Support PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: COPD is a major cause of morbidity and mortality worldwide, representing a major public health problem due to the high health and economic resource consumption. Pulmonary rehabilitation is a standard care recommendation for these patients, in order to control the symptoms and optimize the functional capacity, reducing healthcare costs associated with exacerbations and activity limitations and participation. However, in patients with severe COPD exercise performance can be difficult, due to extreme dyspnea, decreased muscle strength and fatigue. In addition, hypoxemia and dyspnea during efforts and daily activities may occur, limiting their quality of life. Thus, NIV have been used as adjunct to exercise, in order to improve exercise capacity in these patients. However, there is no consensus for this technique recommendation. Our objective was to verify whether the use of NIV during exercise is effective than exercise without NIV in dyspnea, walked distance, blood gases and health status in COPD patients, through a systematic review and meta-analysis. ⋯ Sara Correia: Employee: salary The following authors have nothing to disclose: Teresa Tomás, Elisabete CarolinoNo Product/Research Disclosure Information.